Adderall App Exposed — Insurers Snoozed

A variety of colorful pills and tablets spilled from a brown medicine bottle

A telehealth startup once sold as easy mental health care has now been exposed as a high-tech Adderall pill mill that pushed tens of millions of stimulant pills while insurers and regulators looked the other way.

Story Snapshot

Done Global founder Ruthia He was sentenced to six years in prison and fined $1 million for a massive Adderall distribution and fraud scheme.
Prosecutors say the company used its app, pay model, and clinical rules to unlawfully send out more than 37 million Adderall pills and steal over $12 million from insurers.
Clinicians allegedly prescribed stimulants in 30‑second bursts, while clinical president David Brody personally ordered nearly 400,000 pills for patients he never examined.
The case highlights how emergency telehealth rules opened the door for industrial‑scale drug dealing online, deepening public distrust in both government and digital health.

Telehealth Founder Sentenced for Massive Adderall Scheme

Federal prosecutors say Ruthia He used the digital tools of her company, Done Global, to turn what looked like modern mental health care into a vast Adderall pipeline. The United States Department of Justice states that a judge sentenced her to six years in prison and a $1 million fine for orchestrating a scheme that unlawfully distributed more than 37 million Adderall pills, defrauded insurers of over $12 million, and obstructed the investigation that followed. For many Americans on both the left and right, this reads less like a one‑off crime and more like another example of elites gaming a system that is supposed to protect ordinary patients.

The Justice Department says He built Done’s technology platform, pay structure, and clinical rules in ways that pushed speed and volume over careful medical judgment. Prosecutors describe how patients were funneled through quick online visits, then given stimulant prescriptions with almost no real oversight. A San Francisco jury had already convicted He in November 2025 on charges of conspiracy to distribute controlled substances, multiple counts of illegal distribution, conspiracy to commit health care fraud, and conspiracy to obstruct justice. That mix of drug and fraud charges fits a wider pattern where health care businesses quietly turn into profit machines first and care providers second.

Deceptive Advertising and Assembly‑Line Prescribing

Federal investigators say Done spent more than $40 million on social media ads that were designed to convince stressed Americans they had attention deficit hyperactivity disorder. According to the Internal Revenue Service Criminal Investigation division, the company targeted people struggling with the lack of structure during the COVID‑19 pandemic, then steered them toward Adderall subscriptions. The Department of Justice reports that clinicians working with Done issued Adderall prescriptions at intervals as short as 30 seconds, a pace that looks more like a factory line than a doctor’s office. Many citizens who have watched drug companies and big tech profit off their pain will see this as exactly how the system is rigged.

Clinical president Dr. David Brody became a symbol of that assembly‑line model. Reporting based on court records says he personally prescribed 394,324 stimulant pills to patients he never actually assessed, while referring to stimulants as “candy” and comparing prescribers to Santa Claus. Brody received a two‑year prison sentence and a $1 million fine for his role in the scheme. Prosecutors say Done’s clinicians were pressured to prescribe stimulants even when they believed patients did not have attention deficit hyperactivity disorder, and to auto‑approve refills for people who were in psychiatric holds or even dead. These details deepen fears that profit‑driven health platforms can treat human lives as numbers on a dashboard.

Impact on Patients, Insurers, and Public Trust

The Justice Department says Done distributed Adderall even to people whose existing mental health problems got worse when they took stimulants, including patients with psychosis, bipolar disorder, depression, and anxiety. Court filings cited by federal officials say pharmacies, Medicare, Medicaid, and private insurers were misled into paying tens of millions of dollars for these drugs. Investigators estimate insurers lost more than $12 million directly to Done’s false claims, with Medicare and Medicaid paying at least $14 million for prescriptions tied to the scheme. For many taxpayers who already worry about waste and fraud, this case underscores how easily federal programs and insurers can be exploited when oversight is weak.

Psychiatrist David Brody gets two years prison for Adderall distribution scheme

Former Done Global Clinical President Dr. David Brody has been sentenced to two years in federal prison and fined $1 million for his role in a multimillion-dollar telehealth scheme that illegally…

— PsychCrime (@psychcrime) July 9, 2026

This prosecution is part of a wider federal crackdown on telehealth schemes that took advantage of pandemic‑era rule changes for prescribing controlled substances. Legal analysts note that emergency flexibility around remote prescribing, meant to keep care going during lockdowns, also made it easier for bad actors to push huge volumes of drugs with little face‑to‑face contact. Federal health agencies and watchdogs have warned for years that telehealth can become a vehicle for unnecessary prescriptions, fake billing, and subscription scams if strong guardrails are not in place. Many Americans now see a pattern: crises open doors for new programs, then those programs become playgrounds for well‑connected insiders.

Why This Case Feeds Broader Anger at the System

For conservatives, Done’s scheme looks like the worst mix of big tech, woke‑branded mental health marketing, and federal failure to police illegal drugs until the damage is done. For liberals, it shows how a for‑profit health model can prey on vulnerable people, deepen addiction, and widen the gap between corporate winners and ordinary families. Both sides can see how emergency telehealth rules were written by government agencies, then exploited at massive scale before anyone stepped in.

The case also raises hard questions about who gets punished and who designs the rules in the first place. Telehealth was sold as innovation, yet oversight trailed far behind money and hype. While He and Brody now face prison, the insurers that paid out millions and the regulators that missed red flags for years will continue largely unchanged. Many citizens already believe the federal government protects powerful players more than patients. This Adderall pill‑mill case, with its mix of high tech, big marketing budgets, and slow accountability, is likely to deepen that belief.